Corpora amylacea act as containers that remove waste products from the brain by Riba Baqués, Marta et al.
Corpora amylacea act as containers that remove waste
products from the brain
Marta Ribaa,b,c,1, Elisabet Augéa,b,c,1, Joan Campo-Sabariza,d, David Moral-Antera,d, Laura Molina-Porcele,
Teresa Ximelise, Ruth Ferrera,d, Raquel Martín-Venegasa,d, Carme Pelegría,b,c,2, and Jordi Vilaplanaa,b,c,2
aSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Universitat de Barcelona, 08028 Barcelona, Spain; bInstitut de Neurociències, Universitat de
Barcelona, 08035 Barcelona, Spain; cCentros de Biomedicina en Red de Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain; dInstitut de
Recerca en Nutrició i Seguretat Alimentàries (INSA-UB), Universitat de Barcelona, 08291 Barcelona, Spain; and eNeurological Tissue Bank of the Biobanc-
Hospital Clinic-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain
Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved November 5, 2019 (received for review August 8, 2019)
Corpora amylacea (CA) in the human brain are granular bodies
formed by polyglucosan aggregates that amass waste products of
different origins. They are generated by astrocytes, mainly during
aging and neurodegenerative conditions, and are located predom-
inantly in periventricular and subpial regions. This study shows that
CA are released from these regions to the cerebrospinal fluid and
are present in the cervical lymph nodes, into which cerebrospinal
fluid drains through the meningeal lymphatic system. We also show
that CA can be phagocytosed bymacrophages. We conclude that CA
can act as containers that remove waste products from the brain
and may be involved in a mechanism that cleans the brain. Moreover,
we postulate that CA may contribute in some autoimmune brain
diseases, exporting brain substances that interact with the immune
system, and hypothesize that CAmay contain brain markers that may
aid in the diagnosis of certain brain diseases.
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In 1837 the anatomist and physiologist J. E. Purkinje describedthe presence of some particular granular bodies in the brain of
elderly patients (1). Virchow, in 1854, described them in more
detail and observed that these bodies (corpora in Latin) share
some similarities with starch (amylum in Latin) (2). These bod-
ies, named corpora amylacea (CA), were initially considered to
have no pathological significance and for a long time were thought
to be irrelevant. In recent decades, however, this perception has
changed. With the advances in technology, CA have been studied
from different perspectives and a large number of theories re-
garding their nature have been put forward. Unfortunately, none
of these theories have been demonstrated conclusively and CA
remain intriguing and mysterious bodies. In the present study,
several features of CA are described and a vision of their function
is proposed which may have implications for clinical practice.
There is a consensus that the main components of CA are
polymerized hexoses (primarily glucose) (3) and it has been esti-
mated that hexoses constitute about 88% of their weight (4).
Along with polymerized hexoses, other components originating in
neurons, astrocytes, or oligodendrocytes, from blood or of fungal
or viral origin, have also been described, although some of them
have generated controversy (5). In 2017 we reported that CA
contain neoepitopes that are recognized by natural antibodies of
the immunoglobulin M (IgM) isotype (6). We also observed that
these IgMs were present as contaminants in numerous commercial
antibodies used for immunohistochemistry procedures and, since
these contaminant IgMs are recognized by the majority of the
secondary antibodies, they frequently cause false positive immu-
nostaining in CA. These IgMs therefore account for some of the
inconsistencies concerning CA composition and are the main
reason for the uncertainty surrounding their origin and functions.
In subsequent work, we reviewed the presence of the components
previously described in CA and were able to rule out some of them,
at least at levels that can be detected by immunohistochemistry (5,
6). Nonetheless, we observed that CA contain glycogen synthase
(GS), an indispensable enzyme for polyglucosan formation, and
also ubiquitin and protein p62, both associated with processes of
elimination of waste substances (5). The relationship between CA
and waste substances is recurrent in the literature. Already in 1999,
after a detailed and complete review, Cavanagh indicated that “CA
functions seem to be directed towards trapping and sequestration
of potentially hazardous products of cellular metabolism, princi-
pally derived from the aging process, but probably also from any
disease state resulting in excessive amounts of potentially harmful
metabolic products” (3). Although some of these hazardous
products were described after carrying out unreliable immunohis-
tochemical procedures, the results obtained using other techniques
have supported their presence. In this regard, ultrastructural
studies by Sbarbati et al. (7) indicated that CA originate in astro-
cytes and accumulate abnormal material, and the study by Augé
et al. (8) showed that CA are formed inside astrocytes by the ac-
cumulation of residual products, including degenerating mito-
chondria and membranous fragments originating from degenerative
processes. Moreover, combining the results of human neuropath-
ological surveys, cell culture techniques, and animal models, some
authors have proposed that CA are homologous to “Gomori-
positive” granules which accumulate in subcortical/periventricular
regions of the rodent brain and which are derived from damaged
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mitochondria engaged in a complex macroautophagy process (9,
10). For their part, using a combination of 2D electrophoresis
with matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry, Selmaj et al. (11) identified several proteins
of suspected neuronal origin and others involved in the regulation
of apoptosis and senescence, supporting the notion that the bio-
genesis of CA involves the degeneration and aggregation of sub-
stances, some of them of neuronal origin. Moreover, Cissé et al.
(12) already described the presence of ubiquitin in CA in high-
performance liquid chromatography (HPLC) studies. Taken to-
gether, this evidence indicates a relationship between CA and waste
elements and reinforces the idea that CA are waste containers
formed by a polyglucosan structure that amasses waste products (6).
It is well known that CA are located mainly in perivascular,
periventricular, and subpial regions of the brain (4). Since the
glymphatic system drains the interstitial fluid (ISF) from the
perivascular regions to the cerebrospinal fluid (CSF) (13), and
since both periventricular and subpial regions are close to the
cavities that contain the CSF (i.e., ventricles and subarachnoid
space), it is plausible that, as several authors have proposed, CA
are expelled from the brain to the CSF (3–7, 14). In biopsied
material from the vestibular root entry zone in cases of Ménière’s
disease, Sbarbati et al. (7) observed at ultrastructural level that CA
were sited in astroglial processes of the glia limitans, near the pial
region. Around these CA the astrocytic cytoplasmic membrane
presents folds that create fissures which, according to these au-
thors, may split the CA apart, allowing them to escape into the
pial connective tissue or subpial space. In this regard, in a study
with human hippocampal tissue, we observed the presence of
CA in both the subependymal region and beneath the pia and,
occasionally, inside the CSF of the ventricular region. This evi-
dence (summarized in Fig. 1) seems to indicate a possible route of
escape for the CA into the CSF.
The CSF drains not only via arachnoid granulations, as clas-
sically believed, but also via the recently rediscovered meningeal
lymphatic system (15). The presence of lymphatic vessels col-
lecting CSF at the base of the skull was described for the first
time by Földi et al. (16). Johnston et al. (17) reported connec-
tions between the CSF and nasal lymphatic vessels in humans
and other mammals. Later, lymphatic vessels collecting CSF
were also described lining the dural sinuses by Louveau et al. (18,
19), and new techniques based on magnetic resonance imaging
permit their in vivo visualization (20). From meningeal lymphatic
vessels and subsequent lymphatic vessels, lymph crosses different
cervical lymph nodes (18, 21) before accessing the lymphatic
duct or right thoracic duct, which ultimately drain into the bra-
chiocephalic veins. The images in Fig. 2 sketch the structure of
the meninges, including the meningeal lymphatic system, as well
as the routes of the lymphatic vessels that descend to the neck
and cervical lymph nodes. On this basis, it has been reported that
meningeal lymphatic vessels allow the brain to eliminate mac-
romolecules by collecting them from the CSF (22). Conceivably,
in the same way as waste molecules generated in the brain, it is
possible that CA released from the brain into the CSF escape
from the CSF via the meningeal lymphatic system, reaching the
deep cervical lymph nodes or beyond. The lymphatic capillaries
are formed by overlapping cells that can act as valves leaving
relatively large openings, allowing the passage of macromole-
cules and even cells, and thus also the passage of CA.
Fig. 1. Distribution of CA in human brain and possible extrusion into the CSF. (A) Distribution of CA in cerebrum of 70-y-old brains (· rare, ◦ occasional, ½
common, ● extremely rich, variable). Note that CA tend to be concentrated in the proximity to CSF (mean from 4 cases). Adapted with permission from ref.
4. Copyright 1969 American Medical Association. All rights reserved. (B) Hippocampal section of human brain stained with PAS. CA (magenta spots) can be
observed in the border of the hippocampus. Adapted with permission from ref. 5, which is licensed under CC BY 4.0. (C) Hippocampal section of human brain
stained with α-glial fibrillary acidic protein (α-GFAP) (green), mouse IgMs directed against neoepitopes (red), and Hoechst (blue). Note that almost all CA
(stained with the IgMs) are partially encircled with astrocytic fibrils (stained with α-GFAP). Clustered nuclei (blue staining) in the ventricle are from cells from
choroid plexus. Some CA seem to escape from hippocampus (arrowheads) and one is located inside the ventricle (arrow), all suggesting that CA can be
extruded from brain. (D) Proposed extrusion of CA at the vestibular root entry zone. The CA is generated inside the astrocyte and, after the formation of a
system of ramified scissurae around the CA, it is transferred to the pial connective tissue. m, marginal glia; p, pial connective tissue; arrowheads, scissurae on
astrocyte enveloping the CA. Original image: 3,100×. Adapted from ref. 7 by permission of Oxford University Press.
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As we indicated in previous work, CA contain neoepitopes
that are recognized by natural IgM antibodies (6). Natural IgM
antibodies are generated even before birth, without exposure to
external antigens, and contribute to critical innate immune func-
tions such as the maintenance of tissue homeostasis (24). Carbo-
hydrate epitopes are targets of immune surveillance and natural
IgM antibodies (25, 26). Some of these epitopes are generated de
novo under triggering circumstances in cells or structures of the
body itself, and are thus known as neoepitopes. For instance, in
aging processes there is an increase in the generation of advanced
glycation end products (27), which can act as neoepitopes, and
neoepitopes of carbohydrates have also been described in malig-
nant tumor cells (26, 28). In the case of CA, the interaction be-
tween IgMs and neoepitopes cannot occur inside the brain,
because CA are intracellular structures and thus have a limiting
membrane (7, 8). Moreover, IgMs do not cross the blood–brain
barrier and so do not have access to the brain parenchyma or the
CSF (6). Hence, if CA are extruded from the brain to the CSF and
reach the cervical lymph nodes via the meningeal lymphatic ves-
sels, their interaction with IgMs may take place in the cervical
lymph nodes. Furthermore, since phagocytosis is one of the re-
sponses triggered by natural IgMs, it would be interesting to
examine whether lymph node macrophages can phagocytose
them. It must be pointed out that CA being phagocytosed by
macrophages has been observed in samples from cases of neu-
romyelitis optica, a condition that involves tissue inflammation,
vascular alterations, and probably the disruption of the blood–
brain barrier (29).
Overall, this evidence suggests a mechanism for eliminating
residual substances from the brain in which CA act as waste
containers that are extruded from the brain to the CSF. After-
ward, via the meningeal lymphatic system, CA can reach the
cervical lymph nodes, and macrophages located there may play a
significant role in their phagocytosis. We therefore studied the
possible presence of CA in the CSF, their presence in the cer-
vical lymph nodes, and their interactions with macrophages.
Results
CSF Contains CA. To study the presence of CA in the CSF, we an-
alyzed several CSF samples supplied by the Biobanc-Hospital
Clinic-Institut d’Investigacions Biomèdiques August Pi i Sunyer
(IDIBAPS). According to the standard protocol used at this fa-
cility, samples are centrifuged at 4,000 × g at 4 °C for 10 min and
pellets are rejected in order to clean the CSF of unwanted insoluble
particles or cell debris. The supernatants are then maintained
at−80 °C until used. The study by Sakai et al. (4), in which the authors
isolated CA from brain tissue, indicated that centrifugation at
650 × g during 10 min is enough to produce CA precipitation.
Therefore, as the standard protocol used by the Biobanc would
remove any CA present in the CSF, we asked for samples of
noncentrifuged CSF in order to perform a prospective study. These
CSF samples were extended on slides and were stained with peri-
odic acid Schiff (PAS) or immunostained with human IgMs di-
rected against the neoepitopes (IgMh α-NE). In all cases, we
observed round bodies with sizes and histochemical staining com-
patible with CA, thus suggesting the presence of CA in the CSF.
Representative images of these bodies stained with PAS or with
IgMh α-NE are shown in Fig. 3 A and B, respectively. As the use of
noncentrifuged samples compromises the availability of CSF for
other studies, the Biobanc began to collect the pellets of the CSF
processed according to their protocol instead of rejecting them.
These pellets were used to complete the present study. When
performing the extensions from resuspended pellets of CSF, CA
were also observed stained with PAS (Fig. 3C) and stained with
both α-GS and IgMh α-NE (Fig. 3D). The presence of CA in
pellets of CSF was corroborated by visualizing them at an ultra-
structural level using transmission electron microscopy (TEM). As
shown by the representative images from Fig. 3 E–J, CA from CSF
comprise densely packed, randomly oriented short linear fibers,
which in some cases are concentrated in the central region or in
concentric ring regions of CA. Indeed, these ultrastructural fea-
tures are similar to those of mature CA from the hippocampus
brain tissue (8) and those of mature PAS granules from mice (30),
which are equivalent to CA of human brain. CA from the brain are
encircled by a plasma membrane that confirms their intracellular
and cytosolic location (3, 8), but this membrane is not visible in CA
from the CSF. This suggests that CA may have lost this membrane
during the extrusion process. Sbarbati et al. (7) also suggested this
hypothesis when describing the extrusion of CA to pial connective
tissue from vestibular nerve samples. Scanning electron microscope
Fig. 2. Drainage of CSF via the meningeal lymphatic system. (A) Part of the CSF drains from the subarachnoid space via the lymphatic meningeal system. In
turn, ISF drains to the subarachnoid space via the glymphatic system. These routes allow the elimination of waste elements and macromolecules generated in
the brain tissue. Adapted by permission from ref. 22, Springer Nature: Nature, copyright 2018. (B) The meningeal lymphatic vessels descend to the neck,
where the cervical lymph nodes are located. These nodes are involved in the elimination of waste products (the scheme does not depict the lymphatic vessels
lining the dural sinuses). Adapted from ref. 23. Copyright 2011 Elsevier Masson SAS. All rights reserved.
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(SEM) analysis from pellet samples also confirmed the presence of
CA in CSF (Fig. 3 K–M). As reported many years ago with ref-
erence to CA isolated from brain tissue (4), these bodies present a
spherical shape with a smooth surface. Ripples and crevices may be
observed on the surface, but these are artifacts produced by the
electron beam interacting on the sample. Altogether, these results
indicate that CSF contains CA, thus demonstrating that CA are
extruded from brain to the CSF. Moreover, these results also in-
dicate that CSF pellets can be used to analyze these bodies.
CA Are Present in the Cervical Lymph Nodes. Once the presence of
CA in the CSF is established, the next question is to determine
whether they are eliminated from the CSF. Due to their size
(some 10 μm in diameter) they cannot be eliminated via arachnoid
Fig. 3. Human CSF contains CA. After the extension of uncentrifuged CSF on slides, the staining with PAS (A) and with IgMh α-NE (B) showed the presence of
CA in CSF. When performing the extension from resuspended pellets of CSF, CA were also observed stained with PAS (C) and stained with both α-GS and IgMh
α-NE (D, red and green, respectively). This indicated that pellets of CSF contain CA. The presence of CA in pellets of CSF is corroborated by visualizing them at
an ultrastructural level using TEM (E–J) and SEM (K–M).
Riba et al. PNAS | December 17, 2019 | vol. 116 | no. 51 | 26041
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granulations to dural venous sinuses. However, as noted above,
CSF and their macromolecules are also drained via the meningeal
lymphatic system, and thus CA may be eliminated by this system
and may then be driven to the cervical lymph nodes.
We therefore analyzed cervical lymph nodes from different
cases in order to check the presence of CA. When staining
paraffin-embedded sections of the cervical nodes with PAS we
observed that, although not all sections contain CA, these bodies
were observed in certain sections from all donors (Fig. 4). As can
be seen in Fig. 4A, CA found in the cervical lymph nodes were
generally sited in the subcapsular space or in the trabecular
sinuses that radiate from this space through the parenchyma to
the medullary sinuses. It can also be seen that, although CA are
surrounded by the sinus space, they are not completely free; they
show specific contacts with some lymph node cells. The locali-
zation of these lymph node cells in the trabecular sinuses and
their elongated form suggest that they can be macrophages
entrapping CA. We also analyzed different sections by immu-
nofluorescence techniques. The staining with IgMh α-NE and the
secondary fluorochrome-labeled α-IgMh antibody did not allow
the visualization of CA in the nodes because of the presence of
IgMh in the tissue, which become fluorolabeled and thus masked
CA visualization. However, CA were observed in the nodes when
using IgMs from mouse directed against neoepitopes (IgMm
α-NE) and a secondary fluorochrome-labeled α-IgMm (Fig. 4B).
As shown in previous research (6), the α-IgMm binds to the IgMm
but does not recognize the IgMh. In order to determine what
type of lymph node cells were in contact with CA, we used
double immunostaining with IgMm α-NE and α-FcμR on the one
hand and IgMm α-NE and α-CD35 on the other. The FcμR (or
FAIM3) is an IgM receptor present in some macrophages and
dendritic cells and is related to phagocytotic processes, and
CD35 is a receptor for the C3b component of the complement
system also present in these cells. We observed that cervical
lymph nodes contain some cells that become stained with these
markers, but the cells that are in contact with CA did not stain
with these antibodies (Fig. 4C).
We also analyzed the relationship between the amount of CA
contained in the cervical nodes and the position of these nodes in
the neck, expecting that nodes sited in the lower regions would
have fewer CA than those in the upper regions. We analyzed the
amount of CA in the nodes sited in regions I, II, III, and IV
according to Rouvière’s standard anatomic description (31). Re-
gions I and II are located in the upper plane of the neck, while
region III is located in the intermediate plane and region IV in the
lower plane. Data on these observations can be found in the
Dataset S1. Fig. 4C shows the mean number of CA per section
according to the localization of the node in the neck. The mean
number of CA ± SEM from sections corresponding to the upper
zone (regions I and II) is 1.62 ± 0.31 (n = 13), from the in-
termediate zone (region III) 0.90 ± 0.31 (n = 10), and from the
lower zone (region IV) 0.17 ± 0.17 (n = 6) (Fig. 4D). These results
correspond to the mean of CA per section. Bearing in mind that
each section has a thickness of 8 μm, and considering that the
standard size of a node is around 3 mm in radius, the approximate
mean number of CA per node is about 810 ± 155.45 in the upper
zone, 450 ± 157.17 in the intermediate zone, and 85 ± 83.28 in the
lower zone. Then, an ANOVA was performed with the number of
CA per section as the dependent variable and the zone where the
nodes are located as the independent variable. The ANOVA in-
dicated significant differences in the number of CA according to
zone (F2.26 = 4.74; P < 0.019). Post hoc comparisons (Bonferroni
test) indicated higher numbers of CA in the nodes of the upper
zone than in those of the lower zone (P < 0.017). There were no
significant differences in the number of CA in the nodes of the
intermediate zone compared with the upper and lower zones (P >
0.05). Overall, these results support the idea that CA reach and
become entrapped in the cervical lymph nodes.
Macrophages Phagocytose and Process CA. As indicated above, CA
in cervical lymph nodes were generally found in the subcapsular
space or in the trabecular sinuses and have specific contacts with
some lymph node cells. Although α-CD35 and α-FcμR do not
seem to stain these lymph node cells, the localization of these
cells in the trabecular sinuses and their elongated form suggest
that they may be macrophages entrapping CA.
Subsequently, we used in vitro cultures of macrophages de-
rived from THP-1 cells to analyze their interaction with CA. In
the first attempt, we isolated CA from CSF and opsonized them
with IgMh α-NE, and then added the opsonized CA in the cul-
ture of THP-1–derived macrophages. PAS staining applied to
these samples suggested that macrophages can phagocytose CA.
As illustrated in Fig. 5A, some macrophages are close to CA and
begin to encircle them, while in other cases macrophages com-
pletely encircle CA, suggesting that the CA have been phago-
cytosed. When staining the samples with fluorescent-labeled
phalloidin and fluorescent-labeled α-IgMh we also observed
some CA adhering to the macrophages and others encircled by
them (Fig. 5B). Using confocal microscopy and 3D reconstruc-
tion, which allow observing the structure rotating on itself, we
observed some macrophages that were phagocytosing CA (Fig. 5C)
and also some others containing CA inside them, indicating that the
CA had been phagocytosed (Fig. 5D). Other samples were pro-
cessed for visualization by SEM. SEM images also showed macro-
phages engulfing CA, and some filopodia were seen emerging from
macrophages and coming into contact with the bodies (Fig. 5E).
Altogether, these results indicate that CA opsonized with IgMh can
be phagocytosed by THP-1–derived macrophages.
Unexpectedly, however, controls performed with CA non-
opsonized with IgMs were also phagocytosed by THP-1–derived
macrophages (Fig. 5F). Therefore, although the possibility that
opsonization with IgMs could generate some response cannot be
ruled out, IgM opsonization is not a requisite for CA phagocy-
tosis by THP-1–derived macrophages, and this process must in-
volve other mechanisms than those triggered by IgMs and
α-FcμR. Phagocytosis via the IgM activation of the comple-
ment system (32) can also be ruled out because in our experi-
ments the complement proteins were heat inactivated. Mei Liu
et al. (33) observed that CA are reactive for Con A, a lectin that
binds with high affinity to mannose oligomers, and indicated that
CA contain mannose-rich conjugates. Thus, as mannose conju-
gates can be recognized by mannose receptors sited in macro-
phages and can activate phagocytosis, it may be that mannose
contained on the surface of CA can trigger phagocytosis via
possible mannose receptors sited on THP-1–derived macro-
phages. Accordingly, we first verified that CA are reactive to Con
A. Fig. 5G shows representative images of CA from CSF stained
with Con A, which suggests the presence of mannose in CA. We
then tested the presence of the mannose receptor CD206 in
THP-1–derived macrophages, and observed that actually mac-
rophages became stained with α-CD206, indicating the presence
of this receptor in these cells. Fig. 5H shows a representative
image of a CA (stained with fluorescent-labeled Con A) encir-
cled by THP-1 macrophages immunostained with α-CD206.
These results reinforce the notion that, in the case of THP-1 cells
and with the conditions of the present study, the phagocytosis of
CA is produced via the mannose receptor. However, as will be
discussed below, there may be other redundant mechanisms by
which macrophages can phagocytose CA.
Discussion
For decades now, several functions have been attributed to CA,
all of them proposed on the basis of studies performed in brain
tissue or its extracts. The presence of CA in both the CSF and
the cervical lymph nodes, demonstrated in the present study,
provides another perspective.
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Fig. 4. CA are present in the cervical lymph nodes. (A) Images of sections from different cervical nodes stained with PAS. For each section, a region con-
taining CA is magnified. Note that CA exhibit specific contacts with some lymph node cells (arrowheads). (B) CA (arrowhead) can also be observed by im-
munofluorescence when sections are immunostained by IgMm α-NE (green). Blue staining (Hoechst) corresponds to the nuclei of lymph node cells. (C) Double
staining with IgMm α-NE and α-FcμR (green and red respectively, Left image), and double staining with IgMm α-NE and α-CD35 (green and red respectively,
Right image) indicate that some cells of the cervical lymph nodes contain FcμR and other cells express CD35 (Insets). However, the cells in contact with CA
(arrowheads) did not stain with these antibodies. (D) Mean number (±SEM) of CA per section in the different regions of the neck. The upper region of the
neck contains more CA per section than the lower one (P < 0.05), which suggests that brain CA reach the cervical lymph nodes, and that the nodes may retain
or eliminate them.
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Fig. 5. CA are phagocytosed by THP-1–derived macrophages. (A) Macrophage in contact with an IgMh-opsonized CA (Left) and an IgMh-opsonized CA
phagocytosed by macrophage (Right); PAS staining. (B) Other examples of a macrophage making contact with an IgMh-opsonized CA (Left) and an IgMh-
opsonized CA phagocytosed by macrophage (Right). In these cases, macrophages are stained with fluorescent-labeled phalloidin (red) and IgMh-opsonized CA
are stained with fluorescent-labeled α-IgMh (green). Nuclei are stained with Hoechst (blue). (C) Sequence of images showing a macrophage phagocytosing an
IgMh-opsonized CA from different points of view. The sequence was performed after the 3D reconstruction from images obtained by confocal microscopy.
Phalloidin (red), fluorescent labeled α-IgMh (green), and Hoechst (blue). (D) The same procedure was used to obtain a sequence of images showing an IgMh-
opsonized CA that has been phagocytosed by a macrophage. (E) SEM images also showed macrophages engulfing IgMh-opsonized CA. Some filopodia were
found emerging from macrophages and making contact with the bodies (Insets). (F) Macrophage making contact with a non IgMh-opsonized CA (Left) and a
non IgMh-opsonized CA phagocytosed by a macrophage (Right); PAS staining. These results indicate that IgMh opsonization of CA is not a requirement for
phagocytosis by THP-1–derived macrophages. (G) CA from CSF become stained with fluorochrome-labeled Con A, which suggests that they contain mannose.
(H) CA (stained with Con A, green), encircled by THP-1–derived macrophages immunostained with α-CD206 (mannose receptor, red) and Hoechst (nuclei,
blue). Orthogonal views show macrophages attached to the CA. These results suggest that, in the case of THP-1–derived macrophages and with the conditions
set up in the present study, CA phagocytosis is produced via the mannose receptor.
26044 | www.pnas.org/cgi/doi/10.1073/pnas.1913741116 Riba et al.
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CA are formed by waste elements included in a polyglucosan
structure and their presence in the CSF reveals that they may act
as waste containers removing brain products from the brain to
the CSF. In addition, their presence in the deep cervical lymph
nodes supports the hypothesis that they can leave CSF via the
meningeal lymphatic vessels and reach these nodes. As shown,
the staining properties of the CA found in the cervical nodes
indicate that they are compatible with those described in the
CSF, and their localization in the trabecular sinuses but not in
the parenchyma suggests that they are not generated in the
nodes themselves. In addition, the gradient in the number of CA
observed in the nodes related to their proximity to the brain also
suggests that they arrive there from the CSF. As there are other
structures apart from the brain that generate CA, the possibility
that the CA contained in the cervical nodes come from some of
these other structures must be considered. If this were the case,
then: 1) these structures must generate CA that become stained
with PAS and immunostained with natural IgMs; 2) these
structures must expel the CA directly or indirectly into the lymph;
and 3) the lymph generated must drain toward the cervical lymph
nodes sited in the regions I, II, III, and IV of the neck. To our
knowledge, the brain is the only structure that fulfills the 3 pre-
mises indicated. Structures or organs like mammary glands, car-
diac muscle, or prostate can be ruled out, because the lymph of
these structures does not drain toward the cervical lymph nodes.
On the other hand, CA originating in the thyroid gland and
prostate are calcified structures formed (in the case of prostate) by
a calcified protein matrix (34), and thus are incompatible with the
CA that we described in the cervical lymph nodes. This is also the
case of calculi originating in the salivary gland, which are formed
by hydroxyapatite (34).
Although it might be thought that the presence of CA in the
CSF is merely circumstantial, there are certain indices that
suggest that this presence is the result of some specific physio-
logical processes. The localization of CA mainly in the periven-
tricular and subpial regions of the brain does not seem to be
casual. Moreover, as can be observed in Movie S1 (adapted from
ref. 5), some CA contain a central compact core with a high
presence of ubiquitin and a peripheral region which contains GS,
p62, and ubiquitin. The central core may correspond to a region
where different ubiquitinated waste substances have accumu-
lated, while the peripheral region may correspond to an active
zone where the waste elements are collected by p62 and pack-
aged by GS, which generates the polyglucosan component of the
CA (5). In addition, the presence in CA of neoepitopes that are
recognized by plasmatic natural IgMs suggested that they may be
structures ready to be phagocytosed by macrophages or other
immune cells if they were released from the brain (6, 8). Corre-
spondingly, and as shown here, the CA present in the cervical
lymph nodes were seen adhered to elongated cells compatible with
macrophages, and CA were avidly phagocytosed by THP-1–derived
macrophages. Taken together, these results extend the hypothesis
proposed in Augé et al. (6), according to which CA collect residual
substances and are removed from the brain and then eliminated via
the immune system. Fig. 6 summarizes this route, updating the
scheme proposed in 2017. The pathway begins in the astrocytes
which generate CA to create a kind of waste container formed by
polyglucosan aggregates that amass waste products originating not
only in the astrocytes themselves, but also deriving from neigh-
boring cells. Aging and neurodegenerative conditions increase the
production of waste products, thus enhancing the process. After
their release into the CSF, CA reach the cervical lymph nodes via
the meningeal lymphatic vessels and the subsequent lymphatic
vessels. There, mannose contained in CA can trigger the phago-
cytosis via mannose receptors sited on macrophages, although we
do not rule out other possible mechanisms including the IgM-
FcμR, the IgM-complement pathways, and the lectin pathway
mediated by the C3b opsonization induced by mannose-binding
lectin (MBL). In any case, the immune system may provide re-
dundant mechanisms to ensure the elimination of CA.
Due to the blood–brain barrier and the cerebrospinal fluid–brain
barrier, the brain used to be considered an immune-privileged
organ until the discovery of the meningeal lymphatic system. This
system collects brain substances contained in the CSF, and the
presence of specific brain components outside the brain can in-
teract with the immune system with possibly fatal consequences
(35, 36). It has been reported that cellular and soluble constituents
of the CSF cause immune responses in the cervical lymph nodes
(18), and the possible immunological implications of CSF drainage
via the meningeal lymphatic system were also noted long ago by
Bradbury et al. (37). In this regard, Weller et al. (21) indicated that
“the lymphatic drainage of ISF and CSF and the specialized cer-
vical lymph nodes to which they drain play significant roles in the
induction of immunological tolerance and of adaptive immuno-
logical responses in the central nervous system (CNS)”. Accord-
ingly, and given that the results of the present study indicate that
CA reach the cervical lymph nodes, we cannot rule out the pos-
sibility that, in certain circumstances, the waste substances con-
tained in CA may enhance certain immunological functions or
intervene in some autoimmune alterations. Consequently, and
given their possible clinical implications, the possible role of CA in
immunological processes or brain autoimmune diseases needs to
be investigated.
Our findings may also represent a starting point for the study
of some clinical markers of brain disorders. We know that CA
can contain waste substances produced in the brain and several
of them may be markers of some of these disorders. We also
know that CA are present in both noncentrifuged samples of
CSF and pellets obtained from CSF centrifugation, and so these
structures are easily accessible for study. In recent decades, the
liquid fraction of the CSF has been exhaustively assessed in order
to obtain brain markers. For instance, it is well established that
phospho-tau181, total-tau, and amyloid β1–42 are CSF bio-
markers for Alzheimer’s disease (38). Moreover, promising new
fluid biomarkers for staging and monitoring of frontotemporal
dementia, such as the neurofilament light chain, are emerging
(39, 40). Furthermore, CSF analysis is used to exclude other
diseases in the differential diagnosis of multiple sclerosis (41). In
addition, CSF biomarkers are being studied in patients with
Parkinson’s and are being used in clinical trials (42). However,
the solid fraction of the CSF has not been studied to obtain brain
markers. Our results support the need to study CA contained in
the CSF, postulating that these bodies will contain some of these
markers. As CA from CSF are more accessible than those from
brain tissue, their use for diagnostic purposes may become a
valuable new strategy.
To sum up, our results indicate that CA can act as waste con-
tainers that allow the removal of waste products from the brain
and suggest their involvement in a mechanism that cleans the
brain. Moreover, we hypothesize a role for CA in some autoim-
mune brain diseases, exporting brain substances that interact with
the immune system, and we suggest that they may be important
elements in the diagnosis of certain brain diseases, since they may
contain markers of brain disease.
Methods
Human CSF Samples. Postmortem CSF samples from 16 cases of neuro-
pathologically affected patients (65 to 90 y old) were obtained from the Banc
de Teixits Neurològics (Biobanc-Hospital Clínic-IDIBAPS, Barcelona). Non-
centrifuged samples (n = 7) as well as pellets obtained after centrifugation
at 4,000 × g at 4 °C for 10 min (n = 9) were used. Medical data on these cases
are detailed in SI Appendix, Table S1.
Human Deep Cervical Lymph Node Samples. Paraffin sections (thickness of
8 μm) of cervical lymph nodes taken by lymphadenectomy from 4 cancer
patients (83 to 96 y old) were obtained from the Banc de Tumors i Anatomia
Patològica (Biobanc-Hospital Clínic-IDIBAPS, Barcelona). All selected nodes
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were nontumor affected. Medical data on these cases are detailed in SI
Appendix, Table S2.
All procedures involving human samples were performed in accordance with
appropriate guidelines and regulations. All experiments involving human tissue
were approved by the Bioethical Committee of the University of Barcelona.
Cell Culture and Differentiation. THP-1 cells provided by ATCCwere cultured as
previously described (43). Cells were subcultured at a density of 5 ×104 cells/cm2 on
24-well clusters with 12-mm round cover glasses. Cells were differentiated to
macrophages with phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) at
a concentration of 100 nmol/L in RPMI 1640 (Sigma-Aldrich) supplemented
with 10% heat-inactivated FBS (GE Healthcare Life Sciences), 50 μM
β-mercaptoethanol (Sigma-Aldrich), and penicillin (100 U/mL)/streptomycin
(100 μg/mL) (Life Technologies) for 3 d. Differentiation of PMA-treated cells
was enhanced after the initial 3-d stimulus by removing the PMA-containing
media and then incubating the cells in fresh supplemented RPMI 1640 for a
further 3 d.
Phagocytosis Studies. To study the phagocytosis of CA by macrophages, we
first obtained CA from CSF and opsonized themwith IgMs. CA were obtained
from CSF samples completing 5 centrifugations of CSF at 700 × g for 10 min,
discarding the supernatants, and resuspending the pellets with 500 μL of PBS.
Thereafter, another centrifugation at 700 × g for 10 min was performed, but
the resuspension was obtained with 500 μL of PBS containing IgMh (1:10 di-
lution; OBT1524; AbD Serotec). The resuspension was maintained overnight at
4 °C to obtain the IgM-opsonized CA. Controls were performed with PBS
without IgMs. Thereafter, another centrifugation at 700 × g for 10 min was
performed, and the pellet was resuspended with 1,000 μL of supplemented
RPMI. The samples of 1,000 μL were then added to the wells containing the
THP-1–derived macrophages after removing their media.
Antibodies and Reagents. The following antibodies were used as primary
antibodies: human IgM purified immunoglobulins (1:10 dilution; OBT1524;
AbD Serotec), rabbit monoclonal IgG against GS (1:100; 15B1; Cell Signaling),
IgMs contained as a contaminant in theOX52 antibody (obtained frommouse
Fig. 6. Hypothesized pathway of the elimination of brain waste products based on the role of CA as waste containers. The pathway begins in the astrocytes,
which generate CA building a kind of waste container formed by polyglucosan aggregates that amass waste products originated not only in the astrocytes
themselves, but also derived from neighboring cells (1). CA are then released into the CSF in the ventricular region or subarachnoid space (2a and 2b) or via the
glymphatic system (2c). From there (3), CA enter the meningeal lymphatic vessels (4) and the subsequent lymphatic vessels (5) and reach the cervical lymph nodes
(6). There, macrophages can phagocyte CA via mannose and mannose receptors or via other possible mechanisms that might include the IgM-FcμR, the IgM-
complement pathways, and the lectin pathway mediated by the C3b opsonization induced by MBL and C3b receptors (7). C3, C3 component of the complement
system; C3b, C3b fragment generated from C3; CR, C3b receptor; ManR, mannose receptor; UPS, ubiquitin–proteasome system. (See text for details.)
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ascites), rabbit polyclonal IgG against mannose receptor CD206 (1:1,200;
ab64693, Abcam), mouse monoclonal IgG1 against CD35 (1:40; E11; Thermo
Scientific), and mouse monoclonal IgG1 against FcμR (1:150; OTI1E6; Thermo
Scientific).
The following antibodies were used as secondary antibodies: Alexa Fluor
(AF) 488 goat anti-human IgM heavy chain (1:200; A-21215; Life Technolo-
gies), AF488 goat anti-mouse IgM μ chain specific (1:250; 115-545-075;
Jackson ImmunoResearch Laboratories), AF555 donkey anti-rabbit IgG di-
rected against both heavy and light chains (1:250; A-31572; Life Technolo-
gies), and AF555 goat anti-mouse IgG1 (1:250; A-21125; Life Technologies).
Fluorescein-labeled Con A (Vector Laboratories) was incubated overnight
instead of primary antibodies in some immunohistochemical experiments in
order to detect CA.
Tetramethyl rhodamine-isothiocyanate (TRITC)-phalloidin (Sigma-Aldrich)
was used to stain F-actin frommacrophages. This staining was combined with
the immunohistochemical procedures and was performed by adding TRITC-
phalloidin (1:500) to the secondary antibodies.
Immunofluorescence. Volumes of 40 μL of noncentrifuged CSF or 40 μL of
resuspended CSF pellets (centrifuged 6 times at 700 × g for 10 min and
resuspended each time with PBS) were extended in slides and air dried. They
were then fixed with acetone for 10 min at 4 °C to carry out the immuno-
histochemistry. For lymph node samples, sections were deparaffinized in
xylene and an antigen retrieval step was applied with 10 mM sodium citrate
buffer (pH = 6.0) heated to 100 °C for 40 min. For the cell culture, macro-
phages were washed with Dulbecco’s PBS (DPBS; GIBCO) and fixed in 4%
paraformaldehyde in PBS for 15 min.
Immunofluorescence was performed as follows: samples were rehydrated
with PBS and then blocked and permeabilized with 1% BSA in PBS (Sigma-
Aldrich) (blocking buffer [BB]) with 0.1% Triton X-100 (Sigma-Aldrich) for
20 min. They were then washed with PBS and incubated with the primary
antibody overnight at 4 °C. Next, samples were washed and incubated for 1 h
at room temperature with the secondary antibody. Nuclear staining was
performed with Hoechst (2 μg/mL, H-33258, Fluka) and samples were
washed and coverslipped with Fluoromount (Electron Microscopy Sciences)
or ProLong Gold (Thermo Scientific). Staining controls were performed by
incubating with BB instead of the primary antibody. In double staining,
controls for cross-reactivity of the antibodies were also performed.
PAS Staining. All samples were processed as described in the immunohisto-
chemistry section, except for the macrophage cell culture, in which cells were
only washed with DPBS. Then, samples were stained with PAS according to
the standard procedure. Briefly, samples were fixed for 10 min in Carnoy’s
solution (60% ethanol, 30% chloroform, and 10% glacial acetic acid).
Thereafter, the samples were pretreated for 10 min with 0.25% periodic acid
(19324-50, Electron Microscopy Sciences) in distilled water followed by a
washing step for 3 min. Then, the samples were immersed in Schiff’s reagent
(26052-06, Electron Microscopy Sciences) for 10 min. After Schiff’s reagent,
samples were washed for 5 min in distilled water. Nuclei were counter-
stained for 6 min with a hematoxylin solution according to Mayer (3870,
J. T. Baker). Then, the samples were washed, dehydrated to xylene, and
coverslipped with a quick mounting medium (Eukitt, Fluka Analytical).
Sample Processing for Transmission Electron Microscopy. CSF samples were
postfixed for 1 h using 4% paraformaldehyde and 0.1% glutaraldehyde in
phosphate buffer (PB) 0.1M. Next, samples were centrifuged at 700 × g for 10
min and washed 4 times with PB 0.1 M for 10 min. Then, they were stained
with 1% OsO4 in PB and containing 0.8% potassium ferricyanide for 1 h at
4 °C, dehydrated in acetone at 4 °C, and finally embedded in Spurr resin. The
resin was polymerized for 48 h at 80 °C. Semithin sections (1-μm thickness)
were obtained and, after methylene blue staining, CA were localized. Ul-
trathin sections (70-nm thickness) were obtained using an ultramicrotome
(Leica Ultracut) and a diamond knife (Diatome), and the sections were then
placed on copper grids and poststained with uranyl acetate and lead citrate.
Sample Processing for Scanning Electron Microscopy. CSF samples and mac-
rophages were postfixed using 2.5% glutaraldehyde in PB 0.1 M. Next, they
were washed 3 times with PB 0.1 M for 10 min. Then, samples were stained
with 1% OsO4 in PB and containing 0.8% potassium ferricyanide for 1 h
30 min at 4 °C and dehydrated in alcohols at 4 °C. Next, they were processed
either via critical point drying or air drying with hexamethyldisilazane. Fi-
nally, they were mounted and sputter coated (carbon or gold).
Image Acquisition and Processing. Images were captured with a fluorescence
laser in an optical microscope (BX41, Olympus) and stored in TIFF format. All of
the images were acquired using the same microscope, laser, and software
settings. Exposure time was adapted to each staining, but the respective control
images were acquired with the same exposure time. Image analysis and
treatment were performed using the ImageJ program (NIH). Images that were
modified for contrast and brightness to enhance their visualization were pro-
cessed in the sameway as the images corresponding to their respective controls.
In order to study the CA on cell cultures, image stacks were taken with a
confocal laser scanning microscope (LSM 880, Zeiss) and 3D animations were
obtained by means of the ImageJ program (NIH).
Ultrathin sections were examined using a JEOL JEM-1010 transmission
electronmicroscope operated at an accelerating voltage of 80 kV. The images
were obtained using a CCD Orius camera (Gatan).
SEM images were observed using a JEOL JSM-7001F scanning electron
microscope.
Statistical Analysis. Statistical analysis was performed with the ANOVA
module of the IBM SPSS Statistics (IBM). Significant differences were con-
sidered when P < 0.05.
Data Availability Statement. All data are available in the manuscript and
supporting information.
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